Next, the effects of BACE1 inhibitor infusion were examined in a mouse model overexpressing human APP, the hAPP23 mouse (31), which has higher expression of APP than hAPPSw, and exhibits early cognitive impairment and extensive Aβ pathology (at 3–6 months) (32). Here, APP is linked to Cognitive impairment.